Get the Stockscreener App
5.43
0.74%
0.04
Generation Bio Co stock is traded at $5.43, with a volume of 14,160.
It is up +0.74% in the last 24 hours and down -1.99% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$5.39
Open:
$5.37
24h Volume:
14,160
Relative Volume:
0.25
Market Cap:
$36.59M
Revenue:
$21.23M
Net Income/Loss:
$-72.42M
P/E Ratio:
-0.8017
EPS:
-6.7728
Net Cash Flow:
$-81.69M
1W Performance:
+1.88%
1M Performance:
-1.99%
6M Performance:
+41.78%
1Y Performance:
-54.37%
1-Day Range:
$5.33
$5.51
1-Week Range:
$5.22
$5.64
52-Week Range:
$3.004
$13.00
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
5.43 | 36.32M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
What analysts say about Generation Bio Co stockTechnical Resistance Breaks & Master Stock Selection - earlytimes.in
Generation Bio (GBIO) Price Target Increased by 13.40% to 30.94 - MSN
Is Generation Bio Co. stock gaining market share2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
How Generation Bio Co. stock performs in weak economyJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing - Via TT
Is Generation Bio Co. stock overvalued by current metricsWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
What catalysts could drive Generation Bio Co. stock higherPrice Action & Free Technical Confirmation Trade Alerts - Newser
Generation Bio (GBIO) Stock Analysis Report | Financials & Insights - Benzinga
Here's Why We're A Bit Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation - Yahoo Finance
Layoff Tracker: Valneva Terminates 30 Amid Site Closure - BioSpace
Can Generation Bio Co. stock sustain institutional interest2025 Institutional Moves & Consistent Growth Equity Picks - moha.gov.vn
CEO McDonough Acquires 366 Of Generation Bio Co [GBIO] - TradingView
[Form 4] Generation Bio Co. Insider Trading Activity - Stock Titan
Can Generation Bio Co. stock surprise with earnings upsideMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Will Generation Bio Co. stock deliver consistent dividendsPortfolio Return Report & Long-Term Growth Plans - newser.com
Why Generation Bio Co. stock remains a top recommendationGap Down & Real-Time Stock Entry Alerts - newser.com
Why Generation Bio Co. stock remains resilientWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Using data models to predict Generation Bio Co. stock movement2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Ranking Generation Bio Co. among high performing stocks via toolsWeekly Stock Analysis & Risk Managed Investment Strategies - newser.com
How Generation Bio Co. stock reacts to inflationary pressuresWeekly Stock Analysis & Safe Capital Investment Plans - newser.com
Heatmap analysis for Generation Bio Co. and competitorsPortfolio Value Report & Risk Adjusted Swing Trade Ideas - newser.com
Is Generation Bio Co. stock poised for growthMarket Performance Report & Growth Focused Investment Plans - newser.com
Generation Bio Co. Reports Strategic Restructuring and Financial Highlights - MSN
Why Generation Bio Co. stock could see breakout soonSell Signal & High Return Trade Opportunity Guides - newser.com
Why analysts upgrade Generation Bio Co. stockJuly 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com
Using data filters to optimize entry into Generation Bio Co.Quarterly Trade Summary & Daily Volume Surge Trade Alerts - newser.com
Is this a good reentry point in Generation Bio Co.July 2025 Breakouts & Safe Swing Trade Setups - newser.com
What’s next for Generation Bio Co. stock priceDay Trade & Real-Time Price Movement Reports - newser.com
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):